Tolmar Therapeutics Inc (atrx)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track

Stock chart

Ticker: atrx

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2004-11-16	2004-11-16	PS Planned sale	DUNCAN MICHAEL R VP and General Manager Officer	5,000 -87.5% 30.78 USD 153,900	5,000 -87.5%	30.78	USD 153,900
2004-11-12	2004-11-11	PS Planned sale	GARRETT J STEVEN Senior VP Clinical Research Officer	4,500 -55.1% 30.58 USD 137,610	4,500 -55.1%	30.58	USD 137,610
2004-11-08	2004-11-05	PS Planned sale	BETHUNE DAVID R CEO/Chairman Executive Director	10,000 -6.4% 31.01 USD 310,100	10,000 -6.4%	31.01	USD 310,100
2004-10-19	2004-10-18	PS Planned sale	DUNCAN MICHAEL R VP and General Manager	800 -52.8% 30.14 USD 24,108	800 -52.8%	30.14	USD 24,108
2004-10-19	2004-10-18	PS Planned sale	DUNCAN MICHAEL R VP and General Manager	4,200 -85.5% 30.14 USD 126,567	4,200 -85.5%	30.14	USD 126,567
2004-10-12	2004-10-11	PS Planned sale	GARRETT J STEVEN Senior VP Clinical Research	1,200 -24.7% 30.39 USD 36,468	1,200 -24.7%	30.39	USD 36,468
2004-10-12	2004-10-11	PS Planned sale	GARRETT J STEVEN Senior VP Clinical Research	3,800 -43.8% 30.39 USD 115,482	3,800 -43.8%	30.39	USD 115,482
2004-10-06	2004-10-05	PS Planned sale	BETHUNE DAVID R CEO/Chairman Executive Director	10,000 -6.4% 32.02 USD 320,190	10,000 -6.4%	32.02	USD 320,190
2004-09-16	2004-09-16	PS Planned sale	DUNCAN MICHAEL R VP and General Manager Officer	3,300 -85.7% 30.12 USD 99,396	3,300 -85.7%	30.12	USD 99,396
2004-09-16	2004-09-16	PS Planned sale	DUNCAN MICHAEL R VP and General Manager Officer	1,700 -75.6% 30.12 USD 51,204	1,700 -75.6%	30.12	USD 51,204
2004-09-14	2004-09-13	PS Planned sale	GARRETT J STEVEN Senior VP Clinical Research Officer	5,000 -58.8% 30.00 USD 150,000	5,000 -58.8%	30.00	USD 150,000
2004-09-08	2004-09-07	PS Planned sale	BETHUNE DAVID R CEO/Chairman Executive Director	10,000 -6.4% 29.21 USD 292,100	10,000 -6.4%	29.21	USD 292,100
2004-08-16	2004-08-16	PS Planned sale	DUNCAN MICHAEL R VP and General Manager Officer	1,000 -64.5% 30.11 USD 30,110	1,000 -64.5%	30.11	USD 30,110
2004-08-16	2004-08-16	PS Planned sale	DUNCAN MICHAEL R VP and General Manager Officer	4,000 -87.9% 30.11 USD 120,440	4,000 -87.9%	30.11	USD 120,440
2004-08-11	2004-08-11	PS Planned sale	GARRETT J STEVEN Senior VP Clinical Research Officer	5,000 -58.8% 30.53 USD 152,650	5,000 -58.8%	30.53	USD 152,650
2004-08-05	2004-08-05	PS Planned sale	BETHUNE DAVID R CEO/Chairman Executive Director	10,000 -6.4% 30.57 USD 305,700	10,000 -6.4%	30.57	USD 305,700
2004-07-19	2004-07-19	PS Planned sale	WARREN STEPHEN L VP R&D and CSO	5,000 -100.0% 33.50 USD 167,500	5,000 -100.0%	33.50	USD 167,500
2004-07-19	2004-07-16	S Sale	DUNCAN MICHAEL R VP and General Manager	7,000 -92.7% 33.50 USD 234,500	7,000 -92.7%	33.50	USD 234,500
2004-07-12	2004-07-12	PS Planned sale	GARRETT J STEVEN Senior VP Clinical Research	5,000 -41.3% 31.96 USD 159,775	5,000 -41.3%	31.96	USD 159,775
2004-07-06	2004-07-06	PS Planned sale	BETHUNE DAVID R CEO/Chairman Executive Director	10,000 -6.4% 33.04 USD 330,400	10,000 -6.4%	33.04	USD 330,400
2004-06-16	2004-06-16	PS Planned sale	GARRETT J STEVEN Senior VP Clinical Research Officer	1,200 -14.5% 32.77 USD 39,324	1,200 -14.5%	32.77	USD 39,324
2004-06-16	2004-06-16	PS Planned sale	GARRETT J STEVEN Senior VP Clinical Research Officer	3,800 -34.9% 32.77 USD 124,526	3,800 -34.9%	32.77	USD 124,526
2004-06-08	2004-06-07	S Sale	BETHUNE DAVID R CEO/Chairman Executive Director	10,000 -6.4% 28.50 USD 284,950	10,000 -6.4%	28.50	USD 284,950
2004-05-17	2004-05-17	S Sale	GARRETT J STEVEN Senior VP Clinical Research	2,000 -15.5% 27.02 USD 54,030	2,000 -15.5%	27.02	USD 54,030
2004-05-10	2004-05-05	S Sale	BETHUNE DAVID R Chief Executive Officer Executive Director	10,000 -6.4% 31.16 USD 311,620	10,000 -6.4%	31.16	USD 311,620
2004-04-19	2004-04-16	S Sale	GARRETT J STEVEN Sr VP Clincal Research Officer	2,000 -13.4% 29.26 USD 58,520	2,000 -13.4%	29.26	USD 58,520
2004-04-06	2004-04-05	S Sale	BETHUNE DAVID R Chairman and CEO Executive Director	10,000 -6.4% 26.34 USD 263,410	10,000 -6.4%	26.34	USD 263,410
2004-03-22	2004-03-19	B Purchase	VUTURO GEORGE J Non-Executive Director	10,000 +61.2% 24.53 USD 245,300	10,000 +61.2%	24.53	USD 245,300
2004-03-22	2004-03-19	S Sale	YARBOROUGH CODY L VP Dermatology Division Officer	900 -81.8% 24.80 USD 22,320	900 -81.8%	24.80	USD 22,320
2004-03-22	2004-03-19	S Sale	YARBOROUGH CODY L VP Dermatology Division Officer	500 -31.2% 25.00 USD 12,500	500 -31.2%	25.00	USD 12,500
2004-03-17	2004-03-16	S Sale	GARRETT J STEVEN Sr VP Clinical Research Officer	1,500 -10.4% 24.26 USD 36,390	1,500 -10.4%	24.26	USD 36,390
2004-03-17	2004-03-15	S Sale	YARBOROUGH CODY L VP Dermatology Division Officer	500 -71.4% 25.23 USD 12,615	500 -71.4%	25.23	USD 12,615
2004-02-19	2004-02-17	S Sale	YARBOROUGH CODY L VP Dermatology Division	500 -71.4% 26.90 USD 13,450	500 -71.4%	26.90	USD 13,450
2004-02-19	2004-02-17	S Sale	GARRETT J STEVEN Sr VP Clinical Research	2,000 -12.2% 26.90 USD 53,800	2,000 -12.2%	26.90	USD 53,800
2004-01-20	2004-01-16	S Sale	GARRETT J STEVEN Senior VP Clinical Research Officer	2,000 -10.9% 25.05 USD 50,100	2,000 -10.9%	25.05	USD 50,100

Tolmar Therapeutics Inc (atrx)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by